Blood Doping

Introduction: The "Olymp" gun has already caused the 100 meter sprint of the 1988 Olympic Games. If there is a shiny blue baffle Canadian Ben Johnson will soon come out. Within 10 seconds, he won his first and only gold medal. He created 79 world records. He is almost inhuman. In that game, he looked faster than the speed of light. He is in cloud 9, and the fans of his worship are the same, but they all fall to the bottom of the rock from their clouds. The Olympic official said, "As light stimulants spread from fraud through the Internet, they become viruses."

Blood stimulants and erythropoietin: blood stimulants are the habit of intravenously injecting blood into individuals to induce erythrocytosis (increase in red blood cell count). This process can be autologous (autologous) or allogeneic (donated). Erythropoietin is derived from the kidney and is a naturally occurring hormone that regulates the number of red blood cells in the body. Erythropoietin is now synthetically produced and can be administered by injection. When used for non-therapeutic purposes, erythropoietin causes changes similar to blood stimulants in the body. This means that more red blood cells can be used to move oxygen.

A blood irritant is an act of misusing a specific technology or substance to increase the quality of erythrocytes in the body. Since red blood cells carry oxygen to the muscles, this allows the body to supply more oxygen to working muscles, thereby increasing their aerobic capacity and endurance. There are three well-known substances or methods for doping blood, erythropoietin (EPO), synthetic oxygen carrier and transfusion *. The primary use of transfusion and synthetic oxygen carriers is for patients experiencing massive blood loss during major surgery or severe trauma. Erythropoietin is used to treat anemia associated with kidney disease. However, if you exploit these substances and techniques, the following may occur.

A blood stimulant is to inject whole blood into an athlete. It has the same effect as highland training and it is also popular with endurance athletes. The risk of transfusion patients who are not exercising, in particular the risk of acquired virus infection and blood volume overload, is the same. There is currently no guarantee on how to detect blood irritants. There are many different forms of erythropoietin, EPO - α, β, δ, ω and zeta being the most common clinically. EPO Z (zeta) is not currently detected in the urine and was patented in Italy by Italian pharmaceutical company Eifa in September 2010. The Chinese also produced EPO which can not be detected.